Abagovomab maintenance therapy in patients with epithelial ovarian cancer after complete response (CR) post-first-line chemotherapy (FLCT): Preliminary results of the randomized, double-blind, placebo-controlled, multicenter MIMOSA trial Meeting Abstract


Authors: Sabbatini, P.; Berek, J. S.; Casado, A.; Cwiertka, K.; Pinter, T.; Pluzanska, A.; Scambia, G.; Pujade-Lauraine, E.; Vermorken, J. B.; Pfisterer, J.
Abstract Title: Abagovomab maintenance therapy in patients with epithelial ovarian cancer after complete response (CR) post-first-line chemotherapy (FLCT): Preliminary results of the randomized, double-blind, placebo-controlled, multicenter MIMOSA trial
Meeting Title: 46th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 15 Suppl.
Meeting Dates: 2010 Jun 4-8
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-05-20
Start Page: 399s
Language: English
ACCESSION: WOS:000208852004092
DOI: 10.1200/jco.2010.28.15_suppl.5036
PROVIDER: wos
Notes: Meeting Abstract: 5036 -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul J Sabbatini
    262 Sabbatini